The effect of active vitamin D on reducing the development of type 2 diabetes from prediabetes (Phase IV, multicenter, randomized, double-blind, placebo controlled, and parallel group comparison)
Phase 4
Recruiting
- Conditions
- prediabetes (impaired fasting glucose and/or impaired glucose tolerance)
- Registration Number
- JPRN-UMIN000048432
- Lead Sponsor
- Shin Komonji Hospital Department of Endocrinology and Diabetes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 904
Inclusion Criteria
Not provided
Exclusion Criteria
Participants are ineligible if they meet any of the following criteria: have a history of diabetes; participate in other clinical trials; have a history of taking anti-diabetes drugs, other active vitamin D, and/or bisphosphonates within the past three months; are pregnant; have coronary, peripheral, or cerebrovascular disease; or have some types of severe diseases (e.g., mental disorder, collagen disease, renal insufficiency, hepatic insufficiency, or terminal disease).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The development of type 2 diabetes from prediabetes between the two groups after 3-year treatment.
- Secondary Outcome Measures
Name Time Method